Stefanich EG - Search Results

1

Evidence for an asialoglycoprotein receptor on nonparenchymal cells for O-linked glycoproteins.

Stefanich EG, Ren S, Danilenko DM, Lim A, Song A, Iyer S, Fielder PJ. Stefanich EG, et al. J Pharmacol Exp Ther. 2008 Nov;327(2):308-15. doi: 10.1124/jpet.108.142232. Epub 2008 Aug 26. J Pharmacol Exp Ther. 2008. PMID: 18728239

2

Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.

Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, de Sauvage FJ. Fielder PJ, et al. Blood. 1996 Mar 15;87(6):2154-61. Blood. 1996. PMID: 8630374 Free article.

3

Human platelets as a model for the binding and degradation of thrombopoietin.

Fielder PJ, Hass P, Nagel M, Stefanich E, Widmer R, Bennett GL, Keller GA, de Sauvage FJ, Eaton D. Fielder PJ, et al. Blood. 1997 Apr 15;89(8):2782-8. Blood. 1997. PMID: 9108396 Free article.

4

Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice.

Stefanich E, Senn T, Widmer R, Fratino C, Keller GA, Fielder PJ. Stefanich E, et al. Blood. 1997 Jun 1;89(11):4063-70. Blood. 1997. PMID: 9166846 Free article.

5

Dose schedule of recombinant murine thrombopoietin prior to myelosuppressive and myeloablative therapy in mice.

Stefanich EG, Carlson-Zermeno CC, McEvoy K, Reich M, Fielder PJ. Stefanich EG, et al. Cancer Chemother Pharmacol. 2001;47(1):70-7. doi: 10.1007/s002800000203. Cancer Chemother Pharmacol. 2001. PMID: 11221965

6

In vitro internalization, intracellular transport, and clearance of an anti-CD11a antibody (Raptiva) by human T-cells.

Coffey GP, Stefanich E, Palmieri S, Eckert R, Padilla-Eagar J, Fielder PJ, Pippig S. Coffey GP, et al. J Pharmacol Exp Ther. 2004 Sep;310(3):896-904. doi: 10.1124/jpet.104.067611. Epub 2004 Jun 9. J Pharmacol Exp Ther. 2004. PMID: 15190122

7

Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers.

Ng CM, Stefanich E, Anand BS, Fielder PJ, Vaickus L. Ng CM, et al. Pharm Res. 2006 Jan;23(1):95-103. doi: 10.1007/s11095-005-8814-3. Epub 2006 Nov 30. Pharm Res. 2006. PMID: 16308668

8

Translational pharmacokinetics and pharmacodynamics of an FcRn-variant anti-CD4 monoclonal antibody from preclinical model to phase I study.

Zheng Y, Scheerens H, Davis JC Jr, Deng R, Fischer SK, Woods C, Fielder PJ, Stefanich EG. Zheng Y, et al. Among authors: stefanich eg. Clin Pharmacol Ther. 2011 Feb;89(2):283-90. doi: 10.1038/clpt.2010.311. Epub 2010 Dec 29. Clin Pharmacol Ther. 2011. PMID: 21191378 Clinical Trial.

9

A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes.

Stefanich EG, Danilenko DM, Wang H, O'Byrne S, Erickson R, Gelzleichter T, Hiraragi H, Chiu H, Ivelja S, Jeet S, Gadkari S, Hwang O, Fuh F, Looney C, Howell K, Albert V, Balazs M, Refino C, Fong S, Iyer S, Williams M. Stefanich EG, et al. Br J Pharmacol. 2011 Apr;162(8):1855-70. doi: 10.1111/j.1476-5381.2011.01205.x. Br J Pharmacol. 2011. PMID: 21232034 Free PMC article.

10

Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis.

Hsu CL, Lin W, Seshasayee D, Chen YH, Ding X, Lin Z, Suto E, Huang Z, Lee WP, Park H, Xu M, Sun M, Rangell L, Lutman JL, Ulufatu S, Stefanich E, Chalouni C, Sagolla M, Diehl L, Fielder P, Dean B, Balazs M, Martin F. Hsu CL, et al. Science. 2012 Jan 6;335(6064):89-92. doi: 10.1126/science.1213682. Epub 2011 Dec 15. Science. 2012. PMID: 22174130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters